recommended risk stratification strategy for osteoporosis therapy

recommended risk stratification strategy for osteoporosis therapy

  • Low/Moderate-risk patients
    • Oral bisphosphonates (alendronate, risedronate, ibandronate)
    • Zoledronic acid
    • Denosumab
  • High-risk patients aa High-risk patients: old age, prior fracture, very low BMD (T-score <–3), high fall risk, GC use.
    • Zoledronic acid
    • Denosumab
    • Teriparatide
    • Abaloparatide
Scroll to Top